Although no significant change in PD-L1 expression after GANT61 treatment was observed based on the Z-scores and ratios, the GSEA revealed that many genes with low fold-change after GANT61 treatment were found to have a significant effect by working in concert with PD-L1 expression and the PD-1 checkpoint pathway in melanoma. This evidence concerns the gene CD274 and melanoma.